Cytosurge Email Format

Biotechnology ResearchZurich, Switzerland11-50 Employees

Cytosurge is a biotechnology research company based in Glattbrugg, Zurich, Switzerland, operating in the field of single-cell biology. Its core offering centers on a proprietary platform that enables physical access to the same living cell over time, allowing researchers to perform non-destructive sampling, perturbation, and profiling of individual cells to study dynamics and causal relationships. The company emphasizes longitudinal, Same-Cell analysis and mechanobiology measurements, supporting researchers in understanding how baseline cellular states influence future behavior and in assessing mechanical properties at the single-cell level. Its service offerings also include CellEDIT, a CRISPR-based cell line engineering service that can execute precise edits without viral delivery, expanding capabilities for genome manipulation in difficult-to-transfect cells. A notable recent development is a collaboration announced in late 2025 to integrate Cytosurge’s FluidFM OMNIUM platform with Lexogen’s RNA library preparation workflow, expanding the scope of minimally invasive cytoplasmic sampling and downstream sequencing.

Sign up for free to view info

Company overview Employee directory